Real-World Mobilization, Harvest, and Transplant Outcomes in Newly Diagnosed Multiple Myeloma Patients Receiving D-VTd: A UK Centre Experience
Christianne Bourlon(King's College Hospital NHS Foundation Trust), Stella Bouziana(King's College Hospital), Pramila Krishnamurthy(King's College London), Victoria Potter(King's College Hospital NHS Foundation Trust), Arief Gunawan(St Thomas' Hospital), Alison Pratt(King's College Hospital NHS Foundation Trust), Fabio Serpenti(King's College Hospital NHS Foundation Trust), Kirsty Cuthill, Michelle Kenyon(Pfizer (United States)), Matthew Streetly(King's College - North Carolina), Robin Sanderson(King's College Hospital NHS Foundation Trust), Sudarshan Gurung(Medway NHS Foundation Trust), Maheen Ahsan(King's College Hospital NHS Foundation Trust), Stella Bowcock(King's College Hospital), Katharine Bailey(King's College Hospital NHS Foundation Trust), Ana Maestre(Lewisham and Greenwich NHS Trust), Reuben Benjamin(King's College Hospital), Satyajit Sahu(Lewisham and Greenwich NHS Trust), Majid Kazmi, Lalita Banerjee(Maidstone and Tunbridge Wells NHS Trust), Mili Shah, Lianwea Chia(Dartford And Gravesham NHS Trust), Haili Cui(King's College Hospital NHS Foundation Trust), John Robert Jones(East Sussex Healthcare NHS Trust), Sabia Rashid(Lewisham and Greenwich NHS Trust)
Cited by 1
Related Papers
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
|Journal of Clinical Oncology|2004|315